Cargando…
Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil
BACKGROUND: Continuous long-term treatment is recommended to reduce the hepatitis B virus (HBV) viral load. However, as a consequence, resistance mutations can emerge and be transmitted to other individuals. The polymerase (POL) gene overlaps the surface (S) gene. Thus, during treatment, mutations i...
Autores principales: | Mantovani, Nathalia, Cicero, Maira, Santana, Luiz Claudio, Silveira, Carla, do Carmo, Eliane Pereira, Abrão, Paulo Roberto Ferreira, Diaz, Ricardo Sobhie, Caseiro, Marcos Montani, Komninakis, Shirley Vasconcelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898369/ https://www.ncbi.nlm.nih.gov/pubmed/24165277 http://dx.doi.org/10.1186/1743-422X-10-320 |
Ejemplares similares
-
Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
por: Gupta, Ekta, et al.
Publicado: (2023) -
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal
por: Cerva, C., et al.
Publicado: (2017) -
Is Hepatitis Delta infections important in Brazil?
por: Cicero, Maira Ferreira, et al.
Publicado: (2016) -
Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis
por: Zheng, Yihu, et al.
Publicado: (2013) -
Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients
por: Kim, Kwang Min, et al.
Publicado: (2011)